MK2578
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MK2578, covering 2011-11-11 to 2012-03-29. Get the full timeline:
Most recent: Clinical Trial Update: A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease (MK2578-003-AM03-EXT12) [Phase 2]